AstraZeneca’s coronavirus vaccine setback shows why Big Pharma would rather be safe than sorry

Before the AstraZeneca announcement about pausing vaccine trials, its chief executive and the top executives of eight other big pharmaceutical companies gave an unusual statement.

Before the AstraZeneca announcement about pausing vaccine trials, its chief executive and the top executives of eight other big pharmaceutical companies gave an unusual statement.